These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1828519)

  • 21. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of sexual behavior of Long-Evans male rats by drugs acting on the 5-HT1A receptor.
    Rehman J; Kaynan A; Christ G; Valcic M; Maayani S; Melman A
    Brain Res; 1999 Mar; 821(2):414-25. PubMed ID: 10064829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists.
    Detke MJ; Wieland S; Lucki I
    Psychopharmacology (Berl); 1995 May; 119(1):47-54. PubMed ID: 7675949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 8-Hydroxy-2-(di-n-propylamino)tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task.
    Carli M; Tranchina S; Samanin R
    Eur J Pharmacol; 1992 Feb; 211(2):227-34. PubMed ID: 1535320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphé nucleus of the rat.
    Higgins GA; Bradbury AJ; Jones BJ; Oakley NR
    Neuropharmacology; 1988 Oct; 27(10):993-1001. PubMed ID: 2467224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats.
    Freo U; Pietrini P; Pizzolato G; Furey-Kurkjian M; Merico A; Ruggero S; Dam M; Battistin L
    Brain Res; 1995 Apr; 677(2):213-20. PubMed ID: 7552245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
    Söderpalm B; Hjorth S; Engel JA
    Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buspirone, 8-OH-DPAT and ipsapirone: effects on hippocampal cerebellar and sciatic fiber excitability.
    Hiner BC; Mauk MD; Peroutka SJ; Kocsis JD
    Brain Res; 1988 Sep; 461(1):1-9. PubMed ID: 2906267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre- or post-training injection of buspirone impaired retention in the inhibitory avoidance task: involvement of amygdala 5-HT1A receptors.
    Liang KC
    Eur J Neurosci; 1999 May; 11(5):1491-500. PubMed ID: 10215901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 5-HT-1A receptor agonists on CRF-induced behavior.
    Lazosky AJ; Britton DR
    Psychopharmacology (Berl); 1991; 104(1):132-6. PubMed ID: 1831906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants.
    Martin KF; Phillips I; Hearson M; Prow MR; Heal DJ
    Br J Pharmacol; 1992 Sep; 107(1):15-21. PubMed ID: 1422568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT1 receptor agonists attenuate the naloxone-induced jumping behaviour in morphine-dependent mice.
    Berthold H; Fozard JR; Engel G
    Eur J Pharmacol; 1989 Mar; 162(1):19-27. PubMed ID: 2566495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
    Bervoets K; Millan MJ; Colpaert FC
    Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P
    Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists.
    Hjorth S
    Eur J Pharmacol; 1991 Jun; 199(2):237-42. PubMed ID: 1835441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral and neurochemical effects of the serotonin (5-HT)1A receptor ligand spiroxatrine.
    Barrett JE; Hoffmann SM; Olmstead SN; Foust MJ; Harrod C; Weissman BA
    Psychopharmacology (Berl); 1989; 97(3):319-25. PubMed ID: 2524083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional topography of brain serotonergic pathways in the rat.
    Hillegaart V
    Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.